The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
MCM4 as a prognostic biomarker of early-stage lung cancer.
 
Virote Sriuranpong
Honoraria - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; MSD Oncology; Novartis; Pfizer; Roche; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Eisai; MSD Oncology; Novartis; Roche
Research Funding - AstraZeneca; Boehringer Ingelheim; MSD Oncology; Novartis; Pfizer; Roche; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Eisai
 
Sutima Luangdilok
No Relationships to Disclose
 
Poonchavist Chantranuwatana
No Relationships to Disclose
 
Nussara Leeladejkul
No Relationships to Disclose
 
Nopporn Pornpatanarak
No Relationships to Disclose
 
Vichai Benjacholamas
No Relationships to Disclose
 
Piyada Sitthideatphaiboon
No Relationships to Disclose
 
Chanida - Vinayanuwattikun
No Relationships to Disclose
 
Trairak Pisitkun
No Relationships to Disclose